Abstract
Background GAI tools are increasingly used informally for health, yet evidence from low- and middle-income countries (LMICs) is limited. This study generates early evidence on such health systems from the fifth most populous country: Pakistan.
Methods We used a youth-led convergent mixed-methods design among digitally connected urban youth in Pakistan (survey N=1240, 20 interviews). The primary outcome was any GAI use for health. We fitted multivariable logistic regression models and conducted reflexive thematic analysis.
Findings Overall, 69.0% of participants reported using GAI for health. Higher odds of use were observed among women (aOR = 1.57, 95% CI [1.17–2.11], p = 0.003) and youth reporting any mental or physical condition (aOR = 1.82, 95% CI [1.34–2.48], p < .001). Greater trust in AI strongly predicted use (per-level aOR = 4.21, 95% CI [2.98–6.01], p < .001). High confidence using AI (aOR = 1.81, 95% CI [1.11–3.07], p = 0.022), awareness of AI risks (aOR = 1.67, 95% CI [1.20–2.31], p = 0.002), and prior use of other (non-generative) digital health tools (aOR = 4.48, 95% CI [2.59–8.23], p < .001) were also associated with higher likelihood of use. Telemedicine use was significant though weaker in magnitude (aOR = 1.58, 95% CI [1.01–2.54], p = 0.049).
Interviews highlighted three themes: (1) access and affordability driving first-line use; (2) emotional safety and informational support, especially for stigmatized concerns; and (3) perceived empowerment in interpreting tests, organizing symptoms, and preparing for clinical visits.
Conclusion Given constrained, stigmatizing, and costly services, GAI may function as an adjunct “first step” for youth health information and emotional support in Pakistan’s health ecosystem.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Deans Fellowship Research Grant at Habib University. The funder had no role in study design, data collection, analysis, interpretation, or the decision to submit the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Review Committee of Habib University, Karachi, gave ethical approval for this work. Reference: HUERC2025AM1, March 2025
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All quantitative data and code produced in the present study are openly available in OSF at https://osf.io/uk7ct/ Qualitative interview data are not publicly available to protect participant confidentiality but may be made available upon reasonable request.
